Related by context. All words. (Click for frequent words.) 71 activator tPA 69 thrombolytic therapy 69 alteplase 68 clot busting therapy 67 rtPA 67 rt PA 67 intravenous tissue plasminogen 67 chemoradiation therapy 66 bolus dose 65 acute STEMI 65 tissue plasminogen activator tPA 65 tracheal intubation 65 fibrinolytic therapy 65 rFVIIa 64 clot busting medication 64 recombinant tissue plasminogen 64 oral anticoagulation 64 clot busting medications 64 reperfusion therapy 64 GAMMAGARD 63 oral anticoagulant therapy 63 antithrombotic therapy 63 epoetin alpha 63 dose titration 63 antiplatelet medication 63 WBPA 63 intravenous diuretics 62 ancrod 62 DVT prophylaxis 62 IOP lowering 62 clevidipine 62 antiarrhythmic drugs 62 FDG PET scans 62 paracentesis 62 defibrillator implant 62 β blockers 62 atrioventricular block 62 carotid artery stenosis 62 Percutaneous Coronary Interventions 62 percutaneous drainage 62 thrombolytic agents 62 methotrexate monotherapy 62 dosage regimens 62 Thrombolysis 62 dosing cohort 62 symptomatic carotid stenosis 62 Postoperative complications 62 intravenous IV infusion 61 upper gastrointestinal bleeding 61 certolizumab 61 clot dissolving drug 61 preadmission 61 nebulization 61 carotid endarterectomy CEA 61 extubated 61 thrombolytic agent 61 HSCT 61 chest radiographs 61 IV tPA 61 NIHSS score 61 intravenous thrombolysis 61 AGHD 61 intra arterial 61 gadobutrol 61 pacemaker implantation 61 NATRECOR ® 61 revascularization procedure 61 ICD shocks 61 cranial irradiation 61 resynchronization therapy 61 tPA 61 dissolving clots 61 intravenous bolus 61 postoperative complication 61 hemostatic efficacy 60 carotid artery stenting 60 controlled analgesia PCA 60 EGFRIs 60 intradermal injections 60 transthoracic 60 thrombotic complications 60 UA NSTEMI 60 antiarrhythmic drug 60 atherosclerotic renal artery stenosis 60 lung resection 60 tacrolimus ointment 60 intravitreal triamcinolone 60 octreotide LAR 60 MDCT angiography 60 thrombolysis 60 beta blocker therapy 60 drug eluting stent implantation 60 activator rt PA 60 colorectal cancer liver metastases 60 angioplasty stenting 60 revascularization procedures 60 colorectal liver metastases 60 oral corticosteroid 60 occluded catheters 60 thrombolytics 60 BENICAR HCT 60 BRINAVESS 60 palliative radiotherapy 60 pyridostigmine 60 polysomnography PSG 60 NYHA functional class 60 ablative therapy 60 extubation 60 weekly intravenous infusions 60 concomitant antibiotics 60 aspirin beta blockers 60 otamixaban 60 neurosurgical procedure 60 reintubation 60 tinzaparin 60 warfarin therapy 60 Clot busting drugs 60 inhaled iloprost 60 antibiotic prophylaxis 60 periprocedural 60 intracerebral haemorrhage 60 timepoints 60 normothermic 60 ß blockers 60 modified REGENESIS Phase IIb 60 ICD therapy 60 antibiotic regimens 60 thromboprophylaxis 60 elective PCI 60 subconjunctival injection 60 postintervention 59 BoNTA 59 NATRECOR R 59 cerebrovascular accidents 59 ATACAND 59 symptomatic paroxysmal AF 59 tolvaptan 59 hemodynamically stable 59 STEMI patients 59 oral corticosteroids 59 tenecteplase 59 posttransplant 59 thoracoscopic lobectomy 59 upper endoscopy 59 VTE prophylaxis 59 MGd 59 cystoscopic 59 FFR measurements 59 postoperative chemotherapy 59 concomitant medications 59 postsurgical 59 daily subcutaneous injections 59 oral prednisone 59 Arikace 59 CRp 59 Lamictal XR 59 thoracoscopy 59 status epilepticus 59 normothermia 59 external beam radiotherapy 59 evaluable subjects 59 FFR guided treatment 59 NAVISTAR R 59 salmeterol fluticasone 59 Accelerated Partial Breast Irradiation 59 sirolimus eluting stents 59 coronary revascularization 59 postdose 59 postprocedure 59 radioiodine therapy 59 weekly subcutaneous injections 59 perioperatively 59 dose escalation phase 59 COR Analyzer 59 MAS XR 59 ipsilateral stroke 59 anticlotting drugs 59 KRAS mutations occur 59 carotid stents 59 NNT = 59 cardiac perfusion 59 angiographic outcomes 59 dissolving blood clots 59 conventional angiography 59 cefazolin 59 GnRH agonist 59 underwent coronary angiography 59 intravitreal injection 59 insulin detemir 59 ablation procedures 59 virological response 59 bronchoscopic procedure 59 liver resection 59 pentoxifylline 59 mitomycin C 59 severe exacerbations 59 coronary artery bypass grafts 59 diagnostic angiography 59 Primary endpoints 59 electrical cardioversion 59 anti coagulant therapy 59 symptom onset 59 stenoses 59 procedural sedation 59 thrombus aspiration 59 postoperative AF 59 MULTAQ 59 Edwards SAPIEN valve 59 nicardipine 59 HPA axis suppression 59 postoperative morbidity 59 electrophysiologic 59 carotid artery blockage 59 conformal radiotherapy 59 everolimus eluting stents 59 DAPT 59 macrolide antibiotic 59 hypotension bradycardia 59 intravenous heparin 59 maximal dose 59 Intra arterial 59 aldosterone antagonists 59 STELARA ™ 59 stereotactic radiotherapy 59 postoperative radiotherapy 59 postoperative hemorrhage 59 chemoembolization 59 anagrelide 59 systemic corticosteroids 59 riociguat 59 fluticasone salmeterol 59 clinically meaningful improvements 59 dorzolamide 58 CT perfusion 58 intravitreal injections 58 coronary intervention 58 IV bolus 58 antiepileptic medications 58 antithrombotic therapies 58 carotid stenosis 58 inotropic 58 hepatectomy 58 amoxicillin clavulanate 58 BrachySil TM 58 oral prednisolone 58 underwent angiography 58 debulking surgery 58 relapsed MM 58 angiographically 58 haematologic 58 MDCT scans 58 corticosteroid therapy 58 coronary CTA 58 barium swallow 58 PSA nadir 58 clot busters 58 Rheos System 58 asymptomatic hyperuricemia 58 INVEGA ® 58 lipid lowering therapy 58 eculizumab therapy 58 Surgical resection 58 busulfan 58 intradermal injection 58 acutely decompensated heart 58 chemoradiotherapy 58 cardioplegic arrest 58 Urocortin 2 58 ICD implantation 58 antimicrobial prophylaxis 58 Coronary CTA 58 warfarin anticoagulation 58 BETAS 58 cardiac resynchronization 58 MACCE 58 undergoing cardiac catheterization 58 intraperitoneal chemotherapy 58 interventional cardiac 58 intravenous vancomycin 58 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 58 intracoronary 58 cardiac cath 58 HIV HCV coinfected 58 4mg/kg 58 transcranial Doppler 58 paroxysmal AF 58 syncopal episodes 58 myocardial necrosis 58 intermittent dosing 58 dobutamine 58 tumor resection 58 activated partial thromboplastin 58 surgical revascularization 58 Gadavist 58 nebulizer treatments 58 Plicator 58 photocoagulation 58 NSAID therapy 58 hyperacute 58 mL kg 58 asthma exacerbation 58 systolic dysfunction 58 glycoprotein IIb IIIa inhibitors 58 pancreatic resection 58 ALA PDT 58 dimensional echocardiography 58 hepatic insufficiency 58 prognostic variables 58 hepatorenal syndrome 58 nebulised 58 prospective multicenter study 58 arterial occlusion 58 pelvic lymphadenectomy 58 underwent resection 58 mesalamine granules 58 aromatase inhibitor therapy 58 ZOLINZA 58 paricalcitol 58 clinically meaningful improvement 58 flutamide 58 anastomotic leak 58 saline placebo 58 glucocorticoid therapy 58 docetaxel Taxotere ® 58 oral rivaroxaban 58 histrelin 58 myocardial infarct size 58 percutaneous interventions 58 surgical resection cavity 58 EXJADE 58 galiximab 58 CLARITY study 58 preoperative chemotherapy 58 tamponade 58 oral antidiabetic medication 58 pulmonary resection 58 acute ischemia 58 antiplatelet medications 58 biochemical relapse 58 pain palliation 58 antiplatelet drugs 58 AMEVIVE 58 unstable angina UA 58 MYCAMINE 58 intravenous immunoglobulin IVIg 58 dose cohort 58 pulmonary artery catheterization 58 CTEPH 58 myocardial revascularization 58 clot retrieval 58 catheter ablations 58 vessel occlusion 58 noncardiac surgery 57 HBV vaccine 57 antihypertensive therapy 57 GnRH agonists 57 histologically proven 57 Acute renal failure 57 subcutaneous ORENCIA 57 pre operatively 57 sipuleucel T 57 BYSTOLIC 57 fibrinolysis 57 divalproex sodium 57 patients undergoing percutaneous 57 parathyroidectomy 57 KAPIDEX 57 radiochemotherapy 57 unruptured aneurysm 57 IMPACT DCM 57 olanzapine LAI 57 saline infusion 57 systemic corticosteroid 57 platelet inhibitor 57 eplerenone 57 paclitaxel eluting stents 57 ADVEXIN therapy 57 bronchodilation 57 BPH LUTS 57 laxation 57 myocardial infarctions MIs 57 neutropenic sepsis 57 ARCOXIA 57 low dose Iluvien 57 bi ventricular pacing 57 Acute Ischemic Stroke 57 postoperative infections 57 lung nodule 57 treprostinil 57 carcinoid tumors 57 thorough QT 57 APTIVUS r 57 venous thromboembolic disease 57 antiangiogenic therapy 57 recurrent glioma 57 systemic hypotension 57 bolus injection 57 coronary stenting 57 allergen immunotherapy 57 CAMMS# 57 treating acute ischemic 57 artery stenosis 57 symptomatic hyponatremia 57 autologous SCT 57 hypoventilation 57 radiotherapy RT 57 calcineurin inhibitor 57 atrial arrhythmias 57 FIRMAGON 57 primary percutaneous coronary 57 cerebral angiography 57 leukocyte count 57 AF ablation 57 Coronary Artery Bypass Graft 57 transcranial Doppler ultrasound 57 VCUG 57 multidose 57 chronic hemodialysis 57 nonischemic 57 ARB telmisartan 57 thymectomy 57 AZOR 57 hepatic metastases 57 APACHE II 57 cardioverter defibrillator 57 FluCAM arm 57 randomized #:#:# 57 neurocognitive outcomes 57 anticoagulation therapy 57 oncologic outcomes 57 cinacalcet 57 Platinol ® 57 definite stent thrombosis 57 serum phosphorous 57 CARE HF 57 moderately emetogenic 57 glycated hemoglobin levels 57 corticosteroid dose 57 urodynamic 57 percutaneous coronary interventions 57 HeartNet 57 rebleeding 57 antithrombotic agents 57 LVRS 57 venous thrombotic events 57 prophylactic antibiotic 57 DIABECELL ® 57 SCIg 57 PASI scores 57 pericardial effusion 57 prophylactic antibiotics 57 doxorubicin docetaxel 57 pegylated interferon alfa 57 pulmonary artery banding 57 Mitomycin C 57 histologically confirmed 57 iNO 57 NSTE ACS 57 kidney insufficiency 57 cisplatin chemotherapy 57 bypass grafting 57 HIPEC 57 inhaled bronchodilators 57 related bloodstream infections 57 ADHF 57 Efficacy endpoints 57 pharmacodynamic parameters 57 mycophenolate mofetil MMF 57 Therapeutic hypothermia 57 diagnostic modality 57 NIH CPSI 57 coronary stenosis 57 cerebrovascular events 57 fluoroscopy guided 57 Elitek 57 hemoglobin A1c levels 57 Lucentis injections 57 ginkgo extract 57 colesevelam HCl 57 intravenous immunoglobulin 57 CCyR 57 lymph node dissection 57 pamidronate 57 8mg/kg 57 RAS mutations 57 paroxysmal atrial fibrillation 57 liposomal doxorubicin 57 percutaneous intervention 57 COPD exacerbation 57 vasopressor 57 icatibant 57 mg/m2 dose 57 Adjuvant chemotherapy 57 aldosterone antagonist 57 CHOP chemotherapy 57 concurrent chemoradiation 57 coronary CT angiography 57 reinfarction 57 acute ischemic stroke 57 recurrent glioblastoma multiforme 57 foam sclerotherapy 57 EOquin TM 57 clopidogrel therapy 57 chronic thromboembolic pulmonary 57 laser photocoagulation 57 RSD# oral 57 NSTEMI 57 Fully Covered Stent 57 CMV disease 57 uridine triacetate 57 nonsmall cell lung cancer 57 cilostazol 57 subarachnoid hemorrhages 57 neurologic progression 57 lipid lowering medication 57 IV NSCLC 57 CANCIDAS 57 biliary tract cancer 57 transaminase elevations 57 inotropes 57 postoperative bleeding 57 Secondary endpoints 57 postexposure 57 Angiographic 57 thromboembolic complications 57 Zilver PTX stent 57 hemoglobin hematocrit 57 NeuroStar TMS Therapy 57 QT QTc 57 TNF antagonist 57 MAGE A3 ASCI 57 cerebral vasospasm 57 adenotonsillectomy 57 neutropenic patients 57 clot dissolver 57 anti arrhythmic medication 57 narrow QRS 57 intracranial stenosis 57 proliferative retinopathy 57 recurrent malignant glioma 57 urography 57 Pemetrexed 57 adrenalectomy 57 acute myocardial infarctions 57 induce remission 57 PREZISTA r 56 monophasic 56 Carotid Revascularization Endarterectomy vs. 56 FDG PET imaging 56 Secondary efficacy endpoints 56 prospectively enrolled 56 intravesical 56 directed thrombolysis 56 GH deficiency 56 tissue oxygenation 56 cryptogenic stroke 56 antidiabetic drugs 56 moderate renal impairment 56 arteriography 56 ABSORB trial 56 recurrent GBM 56 concomitant AEDs 56 refractory ischemia 56 venous thromboembolism prophylaxis 56 decompressive surgery 56 tachyarrhythmias 56 #beta estradiol 56 antiepileptic drugs AEDs 56 tipranavir r 56 Postoperatively 56 ACE inhibitors beta blockers 56 ascending dose 56 injected subcutaneously 56 radiation therapy SBRT 56 asymptomatic AF 56 methacholine challenge 56 PNH patients 56 transcatheter aortic valve implantation 56 duplex ultrasonography 56 azacytidine 56 genotypic resistance 56 aspirin clopidogrel 56 atherothrombotic events 56 Venous thromboembolism 56 recurrent atrial fibrillation 56 balloon angioplasties 56 androgen ablation 56 symptomatic VTE 56 biologic DMARD 56 clot dissolving medication 56 urothelial cancer 56 surrogate endpoint 56 AdreView 56 adjuvant cisplatin 56 chronic GVHD 56 rituximab Rituxan ® 56 oral amoxicillin 56 reteplase 56 dalteparin 56 microwave hyperthermia 56 asystole 56 cardiopulmonary bypass CPB 56 leukoreduction 56 Perforomist Inhalation Solution 56 nitrofurantoin 56 non squamous NSCLC 56 pleurodesis 56 #mg dose [001] 56 catheter angiography 56 CT perfusion scans 56 perfusion CT 56 TORISEL 56 transrectal ultrasound guided 56 MADIT II 56 EKG readings 56 complete cytogenetic response 56 Vasotrac 56 intracerebral hemorrhage 56 tolterodine 56 NIHSS 56 extracorporeal membrane oxygenation ECMO 56 Psoriasis Area 56 briakinumab 56 Vascugel ® 56 glycoprotein IIb IIIa inhibitor 56 valvular disease 56 mealtime insulin 56 anticoagulant warfarin 56 Gliadel Wafer 56 citalopram hydrobromide 56 INTEGRILIN R 56 NeuroFlo 56 EBUS 56 ritonavir boosted protease inhibitor 56 intrathecal chemotherapy 56 CONCERTA ® 56 COREG 56 Perforomist ™ Inhalation Solution 56 Targretin capsules 56 carotid revascularization 56 #mg/day [002] 56 CINQUIL 56 triamcinolone 56 EVIZON 56 intravenous methylnaltrexone 56 streptokinase 56 palivizumab 56 radical cystectomy 56 Ejection Fraction 56 x ray angiography 56 hyperbilirubinemia 56 Certican 56 Nesiritide 56 tolterodine ER 56 pegylated alpha interferon 56 refractory angina 56 EBRT 56 FOLFOX4 56 antihypertensive agents 56 tumor progression TTP 56 trans urethral resection 56 teriflunomide 56 clopidogrel Plavix 56 transesophageal echocardiography 56 LVSD 56 CPAP adherence 56 NovoTTF #A 56 Defibrillation 56 renal cysts 56 docetaxel chemotherapy 56 binary restenosis 56 Doxil ® 56 opioid analgesia 56 receiving highly emetogenic 56 Secondary endpoints include 56 BPS IC 56 irbesartan 56 Cystoscopy 56 frameless radiosurgery 56 CRT ICD 56 sirolimus stent 56 MitraClip device 56 canakinumab 56 postdischarge 56 lymphadenectomy 56 implant defibrillator 56 NTx ® -# 56 TAXUS Liberte Stent 56 ORENCIA ® 56 APTIVUS ritonavir 56 revascularisation 56 renal biopsy 56 BEXXAR 56 interferon ribavirin 56 ventricular tachycardia VT 56 infusional 56 oral methylnaltrexone 56 verteporfin 56 ARIXTRA 56 esophageal manometry 56 Zevalin consolidation 56 hematologic parameters 56 balloon dilation 56 IFN alfa 56 ejection fractions 56 atrial ablation 56 GP IIb IIIa inhibitors 56 acetazolamide 56 electrocardiogram EKG 56 Actilyse 56 continuous intravenous infusion 56 adult chronic ITP 56 VATS lobectomy 56 reoperations 56 antimuscarinic 56 insulin glulisine 56 5mg/kg 56 Kaplan Meier estimate 56 aerosolized KL4 surfactant 56 reintervention 56 epoprostenol 56 radiographic outcomes 56 clot busting medicine 56 invasive aspergillosis 56 Enhanced External Counterpulsation 56 Diamondback #deg 56 STEMIs 56 intravascular 56 hour bronchodilation 56 endobronchial 56 invasive angiography 56 ventilator weaning 56 immunosuppression therapy 56 methylprednisolone 56 allogeneic HSCT 56 lacunar 56 intravenous antibiotic 56 thoracentesis 56 non valvular atrial 56 DEFINITY R 56 adnexal masses 56 adjunctively 56 polysomnographic 56 carotid artery narrowing 56 ketorolac 56 transesophageal echocardiography TEE 56 neuropsychological assessment 56 eptifibatide 56 fluvastatin 56 subcutaneous infusion 56 intracerebral hemorrhage ICH 56 elevated LDH 56 nonrandomized 56 gastrointestinal perforation 56 PROMUS Element Stent 56 defibrillator implantation 56 eBx 56 underwent liver transplantation 56 decompensated heart failure 56 TAXUS Express Stent 56 diaphragm pacing 56 ALGRX 56 AGILECT R 56 RF ablation 56 APRISO 56 QTcF 56 noninvasive outpatient 56 radiolabeled TM# 56 radical retropubic prostatectomy 56 IELT 56 CINTREDEKIN BESUDOTOX 56 cilengitide 56 carotid stent 56 transcatheter closure 56 intra operatively 56 treated nonsurgically 56 HALO# [002] 56 coronary anatomy 56 virologic breakthrough 56 extracorporeal circulation 56 nasal symptom 56 fingerstick 56 hemodialysis patients 56 valve implantation 56 ACTEMRA TM 56 anticoagulated 56 TMS Therapy 56 nonobstructive CAD 56 inhaled nitric oxide 56 morphometric vertebral fractures 56 TUMT 56 Y BOCS 56 standard chemotherapy regimen 56 Provent Therapy 56 procalcitonin 56 Helixate FS 56 sonographic examinations 56 TURBT 56 perioperative morbidity 56 F FDG PET 56 overnight polysomnography 56 intravenous iv 56 pressure monitoring ABPM 56 topical testosterone 56 parenteral antibiotics 56 Twinrix 56 acromegalic patients 56 posttreatment 56 subcutaneous SC 56 overt nephropathy 56 invasive candidiasis 56 needle aspiration 56 clot busting drug 56 intravenous sedation 56 craniectomy 56 bronchoscopic 56 liposome formulation 56 hemodynamic parameters 56 antiarrhythmic medications 56 Polysomnography 56 omega interferon 56 colectomy 56 prostate carcinoma 56 juvenile idiopathic arthritis 56 revascularizations 56 randomized controlled clinical trials 56 INFERGEN 56 neoadjuvant 55 intracranial hemorrhage ICH 55 EmbraceAC 55 MVax 55 postinjury 55 NCCN guidelines 55 transurethral resection 55 PRADAXA 55 flecainide 55 aPTT 55 sonographic diagnosis 55 ProstaScint 55 acetabular fractures 55 unresectable tumors 55 Insulin detemir 55 nebulized 55 inotropic therapy 55 onabotulinumtoxinA 55 5 Fluorouracil 55 ribavirin RBV 55 Orbital Atherectomy System 55 intravenous morphine 55 anticoagulation 55 pathologic diagnosis 55 antiemetics 55 Tasigna prolongs 55 venous stasis ulcers 55 pulmonary artery catheter 55 RAS blockers 55 RVOT 55 anthracycline therapy 55 MTWA testing 55 dose proportionality 55 REMINYL ® 55 IGRAs 55 Tarceva TM 55 nondiabetic patients 55 SANVAR 55 transaminase levels 55 Liver transplantation 55 transurethral 55 cytoreduction 55 rhGH 55 Skin sterol 55 levosimendan 55 atrial pacing 55 NYHA Class II 55 bioprosthetic valve 55 cardiac resynchronisation therapy 55 metastatic uveal melanoma 55 multicenter randomized controlled 55 bortezomib Velcade 55 prior chemotherapy regimens 55 Embolic Protection Device 55 nonmetastatic prostate cancer 55 RX ACCULINK 55 ATPace TM 55 Allovectin 7 ® 55 urate lowering therapy 55 efalizumab 55 nonemergent 55 artery occlusion 55 atorvastatin #mg 55 alpha blocker 55 amphotericin B 55 dosing interval 55 Phase IIIb study 55 interferon beta 1b 55 FXIII 55 LeadCare II 55 prospectively evaluated 55 atrial tachyarrhythmias 55 Cardiopulmonary bypass 55 ALT flares 55 cardiac glycoside 55 vasospasm 55 RX Acculink 55 dimeglumine 55 MMP inhibitor 55 dosimetric 55 Alteplase 55 OHR/AVR# 55 arterial grafts 55 RRMS patients 55 fosbretabulin 55 EBUS FNA 55 leukotriene modifiers 55 Vivaglobin 55 drotrecogin alfa activated 55 silent ischemia 55 preoperative radiotherapy 55 palifermin 55 computed tomography angiography 55 recanalization 55 trastuzumab Herceptin ® 55 tele ICU 55 cardiac angiography 55 anti angiogenic agents 55 symptomatic intracranial 55 serum aminotransferase levels 55 infliximab Remicade 55 colorectal adenoma 55 Retisert TM 55 death reinfarction 55 unexplained syncope 55 metastatic malignant 55 deferasirox 55 inhaled corticosteroid therapy 55 #mg/m# [002] 55 HoFH 55 mg QD 55 pretransplant 55 STRIDE PD 55 cytotoxic therapy 55 undetectable HBV DNA 55 treat brain aneurysms 55 ICD implants 55 NovoLog ® Mix 55 hypertonic saline 55 Nissen fundoplication 55 dexmedetomidine 55 oral antidiabetes drugs 55 carotid artery stenting CAS 55 saphenous vein grafts 55 radial artery grafts 55 AZILECT 55 Platinol ® cisplatin 55 intraocular inflammation 55 percutaneous transluminal coronary angioplasty 55 KOMBIGLYZE XR 55 XL# SAR# 55 dosing cohorts 55 symptom exacerbation 55 acute coronary syndromes ACS 55 adjuvant therapies 55 secondary efficacy endpoint 55 aortic crossclamp 55 prospectively stratified 55 chromosomal mutations 55 TNF alpha inhibitor 55 inguinal hernia repair 55 BENICAR 55 perioperative mortality 55 clot busting drugs 55 thrombocytopenic 55 anticholinergic agents 55 Noxafil 55 deferoxamine 55 desvenlafaxine succinate 55 postoperative atrial fibrillation 55 remifentanil 55 TYGACIL 55 renal denervation 55 oxypurinol 55 NYHA 55 stratifying patients 55 blocked carotid arteries 55 somatosensory evoked potentials 55 dosing intervals 55 calculated creatinine clearance 55 thromboembolic events 55 quantitative coronary angiography 55 abatacept 55 recurrent VTE 55 TAVR 55 serologic testing 55 chest radiography 55 liver metastasis 55 neurologic sequelae 55 glomerular filtration 55 NCCN Guidelines ™ 55 anterior uveitis